| Q48254997 | A novel gene derived from a segmental duplication shows perturbed expression in Alzheimer's disease |
| Q24805606 | Author's Reply |
| Q35681844 | Chasing genes in Alzheimer's and Parkinson's disease |
| Q47308446 | Contribution of apolipoprotein E and cathepsin D genotypes to the familial aggregation of Alzheimer's disease |
| Q24811200 | Disparities in cognitive functioning by race/ethnicity in the Baltimore Memory Study |
| Q34518584 | Epigenomics of Alzheimer's disease |
| Q44094534 | Evidence for parent of origin effect in late-onset Alzheimer disease |
| Q37185128 | Evidence of shared risk for Alzheimer's disease and Parkinson's disease using family history |
| Q37348964 | Familial risk for Alzheimer's disease alters fMRI activation patterns. |
| Q38027808 | Genetics of dementia: update and guidelines for the clinician |
| Q48858942 | Increasing depressive symptoms in children of Alzheimer parents |
| Q34259694 | Neuroglobin and Alzheimer's dementia: genetic association and gene expression changes |
| Q90447717 | SEMIPARAMETRIC TRANSFORMATION MODELS WITH MULTILEVEL RANDOM EFFECTS FOR CORRELATED DISEASE ONSET IN FAMILIES |
| Q23917446 | Semantic memory activation in individuals at risk for developing Alzheimer disease |
| Q31111440 | Use of functional magnetic resonance imaging in the early identification of Alzheimer's disease |